Biotech – the red-hot, high risk investment story

Biotech - the red-hot, high risk investment story

Biotech stocks have been booming over the last few years. Anyone who has invested will have made some very respectable profits. And it's a bull market that's set to continue for some time yet.

The drugs don’t work: stopping the spread of the superbugs

Antibiotic resistance could turn medical inconveniences into death sentences and become a bigger killer than cancer. Governments and pharmaceutical companies are fighting back. Sarah Moore reports.

Immunotherapy: new hope in the battle against cancer

Immunotherapy is a burgeoning sector that heralds a breakthrough against the world’s second-most deadly disease. Dr Mike Tubbs explains how investors can benefit too.

Invest in helium, biotech, and UK small caps in 2019

We asked our contributors to choose their favourite investment ideas from around the world for this year and beyond. Here’s what they came up with.

Investing in healthcare innovation

The Worldwide Healthcare Trust provides investors with access to exciting opportunities, says Max King.

Where to find the pick of the bunch in biotech stocks

Professional investor Ailsa Craig picks three biotech stocks generating revenues and profits, and which have long-term patent protection.

A memorable day for Biogen investors

Biotech company Biogen’s promising treatment for the most common cause of dementia has just cleared a key hurdle.

Three biotech stocks to buy now

Professional investor Daniel Koller picks three cutting edge three biotech stocks to buy now.

Become a DIY biotech venture capitalist

A new equity crowdfunding platform wants to become the go-to place for investors in early-stage life science companies.

The pharmas making pills tailored to your genes

Reading your genome is becoming easier and cheaper. That makes it possible to figure out which medicines will work for you. Dr Mike Tubbs picks the companies best-placed to profit.

How to invest in the next big medical breakthrough

There is currently no cure for MS, Alzheimer’s and Parkinson’s diseases but research gallops on. There will be big rewards for the first drug company to break through, says Dr Mike Tubbs.

Showing page 1 of 10